Sun Pharmaceutical Industries Ltd.

The sales figure stood at Rs. 71857.40 millions for the March 2025 quarter. The mentioned figure indicates a growth of about 27.43% as compared to Rs. 56391.40 millions during the year-ago period.The company almost doubled its revenue to Rs. 20004.60 millions  from Rs. 8676.00 millions in the quarter ended March 2025.Operating profit for the quarter ended March 2025 rose to 31214.60 millions as compared to 20124.10 millions of corresponding quarter ended March 2024.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202503	202403	% Var	202503	202403	% Var	202503	202403	% Var
Sales	71857.40	56391.40	27.43	230033.30	202751.70	13.46	230033.30	202751.70	13.46
Other Income	3638.10	1188.80	206.03	6239.70	4657.60	33.97	6239.70	4657.60	33.97
PBIDT	31214.60	20124.10	55.11	71620.50	60533.70	18.32	71620.50	60533.70	18.32
Interest	2174.20	2175.90	-0.08	8932.10	7840.80	13.92	8932.10	7840.80	13.92
PBDT	29040.40	17948.20	61.80	62688.40	50502.70	24.13	62688.40	50502.70	24.13
Depreciation	2919.60	3930.40	-25.72	12382.70	16006.20	-22.64	12382.70	16006.20	-22.64
PBT	26120.80	14017.80	86.34	50305.70	34496.50	45.83	50305.70	34496.50	45.83
TAX	6116.20	5341.80	14.50	7479.50	5914.70	26.46	7479.50	5914.70	26.46
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	20004.60	8676.00	130.57	42826.20	28581.80	49.84	42826.20	28581.80	49.84
Equity	2399.30	2399.30	0.00	2399.30	2399.30	0.00	2399.30	2399.30	0.00
PBIDTM(%)	43.44	35.69	21.73	31.13	29.86	4.28	31.13	29.86	4.28